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Abstract: The studies performed till now have pointed to an increased serum levels of interleukin 2 (IL-2) in infection with
hepatitis C virus (HCV). The present study was aimed at examining intrahepatic expression of IL-2 in children (n=15) and in
adults (n=11) with chronic hepatitis C as well as its correlations with histological lesions and selected clinical data. The
immunocytochemical techniques and in situ hybridization method were applied at light and electron microscopy level. Under
the light microscope, expression of IL-2 was analysed semiquantitatively. As compared to the control material, in livers of
both groups of chronic hepatitis C patients augmented expression of IL-2 was demonstrated. The reaction product was localized
mainly in the cytoplasm of hepatocytes which was confirmed by hybridocytochemistry. The mean proportion of cells with
positive reaction for IL-2 mRNA was significantly lower than the proportion of cells positive for the respective protein. No
correlation was disclosed between IL-2 expression on one hand and grading or staging, alanine aminotransferase (ALT) and
HCV RNA levels in serum on the other. At the ultrastructural level, IL-2 in hepatocytes was present mainly in the endoplasmic
reticulum and mitochondria. Our studies have confirmed augmented expression of IL-2 in livers of patients with chronic
hepatitis C and have demonstrated that hepatocytes represent the principal source of the cytokine in HCV in vivo infection.
Moreover, expression of IL-2 in the infection was examined for the first time at the ultrastructural level. Mitochondrial localization
of IL-2 suggests a direct involvement of the cytokine in disturbed function of the organelles. (www.cm-uj.krakow.pl/FHC) 
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Introduction
Ineffective immune response is suggested to play a
principal role in the pathogenesis of chronic HCV
infection. It has been proposed that the immune re-
sponse in chronic hepatitis C is compartmentalized,
with a predominantly Th2 or Th0 response at the
periphery and a Th1 response in the liver [3, 5, 19, 21].
The Th1 cytokines include interleukin 2 (IL-2), the
cytokine most important for cell growth and survival
of T-lymphocytes, natural killer (NK) cells and some
non-lymphoid cells but also known to sensitise T cells
to apoptosis [18]. A significant number of patients
with chronic hepatitis C had elevated IL-2 levels [4]. In
chronic hepatitis C, IL-2 expression was noted to corre-
late with grading and staging [7, 21]. Higher expression
of mRNA for the cytokine was observed also in patients
who failed to react to interferon α (IFN-α) treatment [7],
but circulating levels of IL-2 did not predict the response
to IFN-α treatment [4]. However, reports are also
available on unsuccessful search for genomic IL-2
expression in liver with HCV infection [20]. HCV
itself may directly affect genomic control of IL-2 and
of other cytokines and in this way disturb immune
processes in the liver [2, 32]. The role of hepatocyte-
derived cytokines remains unknown. Our earlier hy-
bridocytochemical studies on mRNA for cytokines in
HCV infection demonstrated transcripts for TNF-α and
IL-1α mainly in cells of liver sinusoids and of inflam-
matory infiltrates, but weaker signal was also demon-
strated in hepatocytes [13].
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The aim of the present study was to investigate the
intrahepatic expression of IL-2 and its mRNA in chronic
hepatitis C in children and adult patients. Our study was
also aimed at the analysis of subcellular localization of
IL-2 in liver biopsy material, since no data on the subject
are available in the literature. Attempts were also made
to correlate the intensity of cytokine expression with (a)
inflammation activity (grading) and/or advancement of
fibrosis (staging), (b) serum alanine aminotransferase
(ALT) levels in groups of adult patients and children and
(c) serum HCV RNA levels in children. 
Materials and methods 
Human liver specimens. The material included liver biopsies ob-
tained from children (n=15) and adults (n=11) with chronic hepatitis
C and with serologically confirmed active replication of the virus.
Anti-HCV tests using ELISA third generation assay (Abbott Park,
Illinois, USA) were positive in all children and all adults, HCV RNA
was found in all children (subject to quantitative appraisal in 13/15
patients) and in all adults. In two children and all adults, qualitative
assay only for HCV RNA was performed using Amplicor HCV test,
version 2.0 (Roche, Mannheim, Germany). The test was standardised
according to the WHO International Standard for HCV RNA. Quan-
titation of HCV RNA was conducted using Digene Sharp Signal
System (Gacthersburg, MD 2878 USA 1201, Cloppe Road). The
mean age of children (9 males, 6 females) at the time of liver biopsy
was 14±1 year (range, 7-17 years) and the mean age of adult patients
(3 males, 8 females) was 44±5 years (range, 22-72 years). All the
tests were routinely performed for diagnostic purposes and before
the anti-viral therapy. The biopsies originated from children of the
Outpatient Clinic of Liver Disease, Specialized Unit for Mother and
Child Health Care in Poznan, Poland and from adult patients of the
Chair of Gastroenterology and Human Nutrition, University of
Medical Sciences in Poznan and Ward of Infectious Diseases, Józef
Strus Hospital in Poznan, where the biopsies were performed in
1999-2003. All patients were seronegative for both HBsAg and
HBeAg antibody, and for IgM antibody against cytomegalovirus
(CMV) or against Epstein-Barr virus (EBV) in standard enzyme
immunoassays (ELISA). Other cases of liver damage (e.g. α1-anti-
trypsin deficiency, Wilsons disease, alcohol dependency) were
ruled out. All the patients exhibited elevated serum alanine amino-
transferase (ALT) level (normal level below 40 IU/L) for at least 6
months. The control group consisted of liver biopsies of serologically
HCV-, HBV-, HCMV-, EBV- and HIV-negative patients with non-
specific changes in the liver (n=4 , children) or chronic hepatitis of
unknown etiology (n=4, adults) (mean age of the control group was
24±8 years; range 9-53 years). All the control patients demonstrated
normal serum ALT activity (below 40 IU/L). Paraffin sections of
reactive lymph nodes from ten patients without liver disease were
used as a positive control.
Tissue preparation. In total, 26 liver biopsy specimens were ob-
tained during routine diagnostic procedures after receiving informed
consent of the patients. For light microscopy, tissue specimens were
fixed in 10% formalin and embedded in paraffin. Histopathological
lesions were evaluated following the classical H+E staining as well
as silver technique and trichrome technique according to Masson and
periodic acid-Schiff with diastase pretreatment. At least 10 sections
were prepared from each biopsy. Each biopsy specimen was evalu-
ated using a simple numerical scoring system for the grade of
portal/periportal necroinflammation (G1) (0-4), the grade of lobular
necroinflammation (G2) (0-4), and for the stage of fibrosis (S) (0-4),
as proposed by Scheuer et al. [26]. The histological lesions con-
sidered to be characteristic of chronic hepatitis were also evaluated.
Histological evaluation was performed independently by two experi-
enced histopathologists. 
For electron microscopy, the material was fixed in paraformalde-
hyde/glutaraldehyde, embedded in epon and ultrathin sections were
subjected to a conventional electron microscopy and immunoelec-
tron microscopy [27]. 
In situ hybridization. For in situ hybridization studies, 5 µm thick
sections were cut and mounted onto SuperFrost/Plus microscope
slides. The digoxygenin-labelled oligoprobe (oligo.pl, IBB PAN,
Warszawa, Poland) specific for human cytokine IL-2 mRNA, show-
ing the following sequence: 5-Dig-TGG TGA GTT TGG GAT TCT
TG-3 was used in dilution 1000 ng/ml and detected with sheep
anti-digoxygenin monoclonal antibodies (MAbs) (Fab fragments),
labelled with horseradish peroxidase (Roche, Mannheim, Germany).
In the hybridocytochemical studies, both classical and amplified by
the ImmunoMax technique [12, 15], sequential sections of the tissue
material pre-tested by immunocytochemical techniques were used.
The in situ hybridization protocol of R&D Systems was employed,
with our own modification and ImmunoMax amplification of the
signal. The subsequent stages involved paraffin removal from the
section using xylene, ethanols and wash in diethyl pyrocarbonate
(DEPC) (Sigma Chemical, St. Louis, USA)-treated distilled water,
each lasting 1-5 min, followed by washing in 0.05 M TRIS (Ac-
cuGene, Maryland, USA) for 5 min at room temperature (RT).
Endogenous peroxidase was blocked by 15 min incubation of the
section in 1% H202 at RT. Then, the sections were digested with
proteinase K (DAKO, Carpinteria, CA, USA), 100-200 (µg/ml for
10-15 min at 37oC. Subsequently, the sections were washed in PBS
for 10 min at RT, fixed again in 0.4% PFA at 4oC for 15 min and
washed in DEPC-distilled water for 1 min. The prehybridization
solution (Sigma) was applied under a coverslip and the preparation
was incubated for 1 h at 37oC. Various concentrations of the oligop-
robe were tested, ranging from 100 to 1000 ng/ml, dissolved in the
prehybridization solution plus 30% formamide. The proper hybridi-
zation took place overnight (16 to 18h) at 38oC, under a coverslip,
in a humid chamber. After removing of the coverslips, the sections
were washed in decreasing concentrations of SSC (Promega Corp.,
Madison, WI, USA) plus 30% formamide (Sigma) and, then, in 0
.1M Tris-HCl, pH 7.6 and 0.1% Triton X-100 in TBS for 15 min at
room temperature. Sheep anti-digoxygenin MAb-horseradish perox-
idase (HRP) (Roche) complex was applied for 45 min at RT in
dilution 1:30. After a wash in PBS/Tween20, biotinylated tyramine
(PerkinElmer Life Sciences, Inc., Boston, MA, USA) was applied at
1:50 dilution for 3 min at RT. The streptavidin-peroxidase complex
was added for 30 min at RT. The hybrids were detected using
peroxidase substrate, 0.05% DAB (DAKO) in 0.05 M Tris/HCl, pH
7.6 supplemented with 0.001% H202, for 5 min at RT. Some sections
were counterstained with hematoxylin.
As controls for in situ hybridization, lymph nodes from ten donors
without liver diseases served as initial positive controls. Negative
controls included (a) hybridization without addition of the molecular
probe and (b) incubations of slides in an RNase A solution (R&D
Systems), 20 mg/ml in 2xSSC/10 mM MgCl2, pH 8, for 30 min at
RT before hybridization. All the experiments were performed at least
twice.
Immunocytochemistry. For immunocytochemistry, the following
specific MAbs were used: (a) mouse anti-human IL-2 antibody
(1:100) (R&D Systems), (b) mouse anti-human CD68 and anti-
human Von Willebrand factor (DAKO EPOS A/S, Denmark ) (both
ready for use dilutions) (DAKO, Glostrup, Denmark). The studies
followed the classical avidin-peroxidase complex (ABC) technique
[9], alone or associated with the ImmunoMax technique [15], de-
scribed in detail in our earlier papers [13]. As controls for immuno-
cytochemistry, lymph nodes from ten donors without liver diseases
served as initial positive controls. Most of the sections were subjected
to double immunocytochemical reactions, including macrophage
 104  A. Kasprzak  et al.
marker (CD68) or marker of endothelial cells (Von Willebrand
factor) and IL-2. The terminal reaction product was visualised using
DAB (brownish-black signal) or DAB supplemented with nickel
(blue colour). Some sections were counterstained with hematoxylin.
Results of the IL-2 expression and expression of its transcript in
reactive lymph nodes (positive control) were not subjected to semi-
quantitative analysis but allowed for quality appraisal of IL-2-spe-
cific antibodies and oligoprobes, used in principal studies.
Immunoelectron microscopy. At the electron microscope level, the
immunocytochemical tests were preceded by examination of IL-2
protein expression on semithin sections using ABC and ImmunoMax
techniques. Ultrathin sections were subjected to a labeling with 15
nm colloidal gold-streptavidin (Biocell Int., Cardiff, UK). The nega-
tive control of the immunocytochemical reaction at the level of
electron microscopy involved substitution of primary antibodies by
a normal serum obtained from the same animal as the primary.
Moreover, the company which produced the antibodies (R&D Sys-
tems) warranted specificity of the antibodies (ELISA tests, results of
Western blot analysis).
Semiquantitative and statistical analyses. The contents of IL-2 and
of respective mRNA in liver biopsies demonstrated using ABC
method and hybridocytochemistry, both combined with Immuno-
Max technique, were assessed by a semiquantitative technique relat-
ing the score of 0 to 4 points to the fraction of stained cells (score 0
- 0% cells, 1 - less than 5% cells, 2 - 5-20% cells, 3 - 20-40% and 4
- more than 40% positive cells). It should be stressed that the
semiquantitative analysis was performed exclusively on sections
stained using the ImmunoMax technique (both in the case of immu-
nocytochemistry and in situ hybridization), in which intense colour
reaction was observed. The slides were examined under a light
microscope, at × 400 magnification. In every section of the liver
biopsy, five fields in hepatic lobules and periportal area and at least
five different portal spaces in each specimen were examined. The
calculations were performed on the mean of three consecutive sec-
tions of liver biopsy material from HCV-infected patients and re-
sulted in mean values, separately for lobular/periportal area and for
portal area. Cellular localization of the studied proteins and the
respective mRNA was evaluated (cell nucleus, cytoplasm, mem-
branes). StatXact Software (Cytel Software Corp.) was used for
statistical analysis of small data sets. In order to determine statistical
significance of variations in the percentage of cells positive for
mRNA-IL-2 and proteins studied, we first calculated the mean values
of immunostaining or hybridocytochemical signal scores for both
liver biopsy groups (adults and children) as well as for control biopsy
specimens, separately for lobular/periportal area and portal spaces.
The values were then compared using the Mann-Whitney U-test for
nonparametric independent data and the Wilcoxon test for nonpar-
ametric dependent data. Correlations between data rows were deter-
mined employing Spearmans rank correlation index. In determining
the correlations, means of the total expression of cytokine mRNA or
of the respective protein were taken into account (i.e. expression in
the lobules, periportal and portal spaces) and related to the sum of
grading (G1+G2), staging (S) and ALT, HCV RNA, respectively, in
the groups of children and adult patients. 
Results
Histology of liver biopsy material
All 26 liver biopsy samples of anti-HCV and HCV-RNA
positive patients were diagnosed by histological criteria
as consistent with chronic hepatitis C. Both the grade of
inflammation and the stage of fibrosis were significantly
lower in children than in adults (grade of inflammation
(G1+G2), 1.8±0.3 vs. 3.4±0.3, respectively, p<0.003)
and stage of fibrosis, 1.0±0.2 vs. 2.6±0.3, respectively,
p<0.0002). In histological patterns, large groups of lym-
phoid cells in dilated portal spaces prevailed in adult
patients (10/11). The infiltrates consisted of individual
lymphoid cells or of their groups. In control liver bio-
psies, nonspecific changes were noted, with individual
cells of inflammatory infiltrate in portal spaces (final
grading, 1.3±0.2), with no traits of liver fibrosis (n=6)
or with fibrosis restricted to portal spaces (n=2) (mean
staging for all patients was 0.3±0.1). 
In situ hybridization
mRNA for IL-2 was demonstrated in all children and in
6/7 examined adult patients (Table 1, 2). Transcript for
IL-2 was located in cells of liver sinusoids (macro-
phages, endothelial cells), in some cells of inflammatory
infiltrates (lymphoid cells, macrophages) and in some
hepatocytes (Fig. 1A,B). The reaction product was de-
Table 1. Score of histological diagnosis, selected clinical data and
semiquantitative assessment of IL-2 and IL-2 mRNA in liver bio-
psies of children with chronic hepatitis type C
Patient,
age (yrs),
sex
Score of
histological
diagnosis1
IL-22,3 ALT
(U/L)
HCV
RNA
(pMol)
G1 G2 S mRNA protein
 1. 14,M 1 0 0 1/1 4/0  56 0.759
 2. 7,F 1 2 3 1/1 4/0 177 0.782
 3. 15,F 1 0 2 1/0 4/0 185 nt
 4. 15,F 1 0 0 1/0 3/0 206 0.733
 5. 15,M 1 2 0 2/0 4/0  53 0.873
 6. 13,M 1 1 1 1/1 3/0  60 nt
 7. 15,F 1 0 1 2/1 4/1  96 0.690
 8. 16,M 2 1 1 2/1 4/1  88 0.705
 9. 14,M 1 1 1 1/1 4/0  37 0.753
10. 17,M 1 0 1 1/0 3/0  68 0.423
11. 17,M 0 0 1 1/1 3/0  73 0.496
12. 15,M 2 1 1 1/1 1/1  95 0.383
13. 12,M 2 1 1 2/1 4/0  68 0.373
14. 8,F 2 0 1 2/1 4/0  18 0.446
15. 14,F 1 0 1 2/0 3/0  24 0.159
Designations: G1 - grading in portal spaces; G2 -grading in lobules;
S- staging; 1Scoring system: see Material and Methods; 2Score: 0 =
negative signal; 1 = less than 5% positive cells; 2 = 5-20% positive
cells; 3 = 20-40% positive cells; 4 = more than 40% positive cells;
nt - not tested; 3The results are expressed by two numbers of which
the first denotes expression in lobules (Kupffer cells, endothelium,
hepatocytes) and the other - expression in inflammatory infiltrates in
portal spaces (lymphocytes, macrophages, endothelium)
Interleukin-2 in livers with hepatitis C virus (HCV) infection         105
tected in the cell cytoplasm. A significantly higher total
expression of mRNA for IL-2 was noted in biopsies from
children and adults with HCV infection as compared to
control liver biopsies (p<0.001; p<0.003, respectively). As
compared to the IL-2 protein-immunopositive cells, much
lower percentage of the cells with the transcript was seen
in children (p<0.002) and in adult patients (p<0.001) both
in the lobules and in the portal spaces (Table 3). No
significant differences between children and adults were
detected in the percentage of cells with total transcript for
the IL-2 (Table 3). In control liver biopsies, mRNA for IL-2
was seen in 2/8 patients. 
Comparative analysis demonstrated a significantly
higher amount of IL-2 mRNA in lobular localization as
compared to portal localization both in children and in
adults with chronic hepatitis C (p<0.01; p<0.03, respec-
tively) (Table 4). 
Immunocytochemistry
IL-2 was detected in all studied HCV-positive patients.
No significant differences were disclosed in IL-2 ex-
pression between children and adults even if the latters
showed much more pronounced grading and staging.
The immunoreactivity for IL-2 was observed mostly in
hepatocytes and only in individual sinusoidal cells or
inflammatory cells. The signal was strong, either evenly
distributed in cytoplasm of hepatocytes or localized in
one of the cell poles (Fig. 2A). The source of IL-2 and
of its mRNA was identified by double staining. As a rule,
immunocytochemical product for IL-2 protein was lo-
calized in hepatocytes and very rarely in cells of liver
sinusoids (Fig. 2B). In the control liver biopsies, only
scattered individual IL-2-positive cells were detected
among hepatocytes and sinusoidal cells. 
In the positive control material (reactive lymph nodes)
co-expression of mRNA for IL-2 and of the protein itself
was demonstrated in a variable number of lymphocytes,
depending on the tested lymph node (Fig. 3). 
The studies confirmed higher sensitivity of the Im-
munoMax technique, as compared to classical immuno-
cytochemical and hybridocytochemical techniques. 
Immunoelectron microscopy 
Application of ABC technique and ImmunoMax tech-
nique on semithin sections confirmed expression and
cellular localization of IL-2 (Fig. 4). At the ultrastructu-
ral level, application of colloidal gold permitted to do-
cument the presence of the protein mainly in enlarged
mitochondria, dilated ER cisternae and the hepatocyte
cytoplasm (Fig. 5A,B). 
Table 2. Score of histological diagnosis, selected clinical data and
semiquantitative assessment of IL-2 and its mRNA in liver biopsies
of adults with chronic hepatitis type C
Patient, age
(yrs), sex
Score of
histological
diagnosis1
IL-22,3 ALT
(U/L)
G1 G2 S mRNA protein
 1. 41,F 2 2 2 1/0 3/1  53
 2. 22,M 1 2 2 2/0 2/0  88
 3. 39,M 1 2 2 1/0 3/0 212
 4. 55,F 3 2 4 2/1 4/0 100
 5. 51,F 2 3 4 1/0 4/0  85
 6. 54,F 2 1 3 nt 3/2  91
 7. 56,F 2 2 2 nt 4/0  56
 8. 72,F 2 2 2 nt 4/0  72
 9. 43,F 1 1 1 nt 4/1  43
10. 27,F 1 1 4 0/0 3/1 100
11. 24,M 1 1 1 1/0 4/1  40
Designations: G1 - grading in portal spaces; G2 -grading in lobules;
S- staging; 1Scoring system: see Material and Methods; 2Score: 0 =
negative signal; 1 = less than 5% positive cells; 2 = 5-20% positive
cells; 3 = 20-40% positive cells; 4 = more than 40% positive cells;
nt - not tested; 3The results are expressed by two numbers of which
the first denotes expression in lobules (Kupffer cells, endothelium,
hepatocytes) and the other - expression in inflammatory infiltrates in
portal spaces (lymphocytes, macrophages, endothelium)
Table 3. Comparative hybridocytochemical and immunocytochemi-
cal scoring of IL-2 and its mRNA in children vs adults with chronic
hepatitis C and in HCV-infected patients vs control biopsy specimens
Cytokine
L+PS
children (n=15) adults (n=11) control (n=8)
mRNA-IL-2 2.07±0.18A 1.29±0.29B 0.25±0.14
IL-2 3.60±0.21*,A 4.00±0.27**,C 0.38±0.16
Data are means ±SE Designations: L+PS - cytokine expression in
hepatic lobules and in portal spaces; *- p<0.002; **- p<0.001 ex-
pression of mRNA vs that of respective protein in each group of
patients; A - p<0.001- expression in the children vs that in the control;
B - p<0.03 and C - p<0.001 - expression in adults vs that in the
control
Table 4. Comparative hybridocytochemical and immunocytochemi-
cal scoring of IL-2 and its mRNA in hepatic lobules (L) and portal
spaces (PS) in children vs adults with chronic hepatitis C
Cytokine
children (n=15) adults (n=11) 
L PS L PS
mRNA-IL-2
1.40±0.13 0.67±0.13 1.14±0.21 0.14±0.11
p<0.01 p<0.03
IL-2
3.40±0.21 0.20±0.11 3.45±0.21 0.55±0.218
p<0.001 p<0.004
Data are means ±SE
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Correlation of IL-2 expression and
grading/staging, ALT or HCV-RNA
In none of the patient groups could significant correla-
tion be disclosed between IL-2 expression (protein and
transcript) on one hand and grading/staging, ALT or
HCV RNA on the other. In children, the correlation
between total IL-2 expression and serum HCV RNA
level was the closest to approach the level of signific-
ance. No attempts to examine such a correlation could
Fig. 1. Fragments of hepatic lobules from patients with chronic HCV infection (A) mRNA for IL-2 in liver sinusoidal cells and (B) in
individual hepatocytes. In situ hybridization, ImmunoMax technique. × 400. Fig. 2. Fragments of hepatic lobules from patients with chronic
HCV infection (A) localization of IL-2 in many hepatocytes (B) double staining for IL-2 expression (blue-grey hepatocytes) and with
anti-CD68 antibodies (brown macrophages). A: × 400, B: × 1000. Fig. 3. Localization of IL-2 in immunoreactive lymph node (positive
control material). ABC-ImmunoMax technique. × 400. Fig. 4. IL-2 localization on semithin section in hepatocytes. ABC-ImmunoMax
technique. × 400.
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be made in adult patients, since in the latters only the
qualitative serum HCV RNA assays were available. In
the HCV-infected adults, the correlation between total
IL-2 expression and ALT activity was the closest to
reach the level of significance. 
Discussion
HCV continues to represent the main causative agent of
the hepatitis which - independently of patients age -
leads to chronic transformation of the process in over
80% patients [1]. In the patients an increase in serum
levels of pro-inflammatory cytokines [17, 30] and up-
regulation of intrahepatic Th1-like cytokines [21] have
been noted. Hepatitis C virus may be resistant to inhibi-
tion by cytokines, so they can play a more prominent role
in liver damage than in controlling or terminating the
viral replication [16, 28]. The in vitro studies demon-
strated a variable effect of HCV proteins on expression
of IL-2 gene [2, 32]. 
The present study represents a continuation of inves-
tigations on IL-2 expression in chronic hepatitis C, deal-
ing in particular with detection of mRNA for IL-2 and
with the localization of the cytokine at ultrastructural
level. IL-2 is known to be produced mainly by Th1 cells
and its role involves stimulation of proliferation and
activation of most T lymphocytes, NK cells and B lym-
phocytes. IL-2 is also known to function in some non-
Fig. 5. Ultrastructural localization of
IL-2 protein in hepatocytes. (A) Gold
particles overlay mainly ER cisternae.
(B) Gold particles overlay mainly di-
lated ER cisternae and enlarged mito-
chondria. Streptavidin-colloidal gold.
TEM, A: × 30 000; B: × 25 000.
 108  A. Kasprzak  et al.
lymphoid cells [24, 29]. The normal and neoplastically
transformed epithelial cells are also capable of express-
ing endogenous IL-2, processed and secreted in the same
way as in hematopoietic cells [25]. Contradictory opi-
nions have been expressed on the amounts of cytokines
detectable in livers of patients with chronic hepatitis C
and on correlation of the cytokine expression on one
hand with grading and/or staging or intrahepatic viral
load on the other [5, 8, 17, 21]. No comparative data are
available on the intrahepatic cytokine expression in
chronic hepatitis C in children and in adults. Our earlier
investigations have shown more pronounced expression
of IL-1α, TNF-α and IL-2 in chronic hepatitis C, and the
proteins have been detected mainly in hepatocytes [13].
The augmented IL-2 expression in patients with chronic
hepatitis C used to be taken as a proof for intrahepatic
Th1 response but cellular sources of the cytokine have
not always been examined [5, 19, 21]. The very low
expression of cytokines in cells of inflammatory infil-
trates in our patients (both in portal spaces and in the
lobules) might have reflected weak stimulation of mono-
nuclear cells, low number of infiltrating activated mac-
rophages (CD68)  or disturbed production of
pro-inflammatory cytokines by cells of the infiltrate.
Studies performed in vitro using the protein NS3 to
stimulate responses of T cells from infected individuals
have shown both, the absence of IL-2 protein secretion
by the lymphocytes and the failure to amplify IL-2
mRNA upon stimulation [6]. Subsequently, various im-
munodominant epitopes of NS3 protein have been dem-
onstrated, which favour IL-2/interferon-γ or IL-10
secretion, respectively [32]. Other authors indicate that
the full-length but not truncated C protein of HCV
activates transcription from the IL-2 promoter in T cells
[2]. Results of the studies may explain the differences in
correlations observed in vivo or in absences of such
correlations between increased IL-2 expression and in-
creased IFN-γ expression, grading and staging in
chronic hepatitis C infection [21]. 
In the present study, the ImmunoMax technique has
been applied for the first time in investigations on IL-2
expression in the liver. It has amplified sensitivity of the
classical imunocytochemical techniques and of in situ
hybridization. We have documented augmented ex-
pression of IL-2 in patients with chronic hepatitis C as
compared to the control liver biopsies. Furthermore,
IL-2 expression was compared between children and
adults with chronic hepatitis C but no significant dif-
ferences could be detected even if histologically detect-
able lesions were much more pronounced in the adult
patients. We have confirmed our earlier observations on
IL-2 expression in hepatocytes, extended at present by
ultrastructural studies which have demonstrated localiz-
ation of IL-2 in regions of endoplasmic reticulum and in
mitochondria . Hepatocytes proved also to be the source
of other cytokines in HCV infection, including IL-1α,
TNF-α and IL-6 [8, 13, 23]. At the ultrastructural level,
only localization of IL-6 has been documented till now,
mainly in endoplasmic reticulum cisternae [11, 23].
Mitochondrial localization of IL-2, observed in the pres-
ent investigations, points to a potential role of the cyto-
kine in damage induced to the organelles and in
morphological lesions, frequent in ultrastructural de-
scriptions of the infection [10]. Semiquantitatively de-
tected higher expression of IL-2 in HCV infections, as
compared to the non-HCV infections in the liver, and the
presence of the expression also in mitochondria in
chronic C hepatitis, may suggest its direct or indirect
relationship with compromised function of the orga-
nelle, e.g., in the scope of fatty acid metabolism, for
which, i.a., cytochrome P450 is responsible. In vitro
studies proved that down-regulation of cytochrome
P450 reflects also over-expression of c-myc in rat hepa-
tocytes, resulting from administration of exogenous IL-2
[31]. The disturbed structure of mitochondria has al-
ready been described in our earlier studies on ultrastruc-
tural patterns noted in chronic HCV infection [10]. The
mechanism (primary or secondary) of the mitochondrial
damage remains unknown. Our team has also described
localization of some HCV proteins (NS3, C) within
mitochondria [14]. The damaged function of mitochon-
dria is frequently linked to augmented cell levels of
oxygen free radicals (ROS) and secondary lipid peroxi-
dation and may show links to the frequently observed
phenomenon of lipid degeneration of hepatocytes in this
viral infection [22].
Augmented expression of IL-2 in hepatocytes of pa-
tients with chronic hepatitis C, as compared to control
livers, points to a significant involvement of the cytokine
in pathogenesis of chronic hepatitis C, independently of the
advancement of histological lesions (grading/staging).
The significantly lower expression of mRNA for
IL-2, as compared to expression of the respective pro-
tein, may reflect lower actual production of the transcript
and/or its higher sensitivity to degradation in paraffin
sections.
References
[ 1] Alter HJ (1995) To C or not to C: these are the questions. Blood
85: 1681-1695
[ 2] Bergqvist A, Rice CM (2001) Transcriptional activation of the
interleukin-2 promoter by hepatitis C virus core protein. J Virol
75: 772-781
[ 3] Bertoletti A, DElios MM, Boni C, De Carli M, Zignego AL,
Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G,
Ferrari C (1997) Different cytokine profile of intrahepatic T
cells in chronic hepatitis B and hepatitis C virus infection.
Gastroenterology 112: 193-199
[ 4] Bozkaya H, Bozdayi AM, Aslan N, Turkay C, Sarioglu M,
Cetinkaya H, Akdogan M, Cinar K, Erden E, Kose K, Senturk
H, Akkiz H, Karayalcin S, Yurdaydin C, Uzunalimoglu O
(2000) Circulating IL-2 and IL-10 in chronic active hepatitis C
with respect to the response to IFN treatment. Infection 28:
309-313
Interleukin-2 in livers with hepatitis C virus (HCV) infection         109
[ 5] Dumoulin FL, Bach A, Leifeld L, El-Bakri M, Fischer HP,
Sauerbruch T, Spengler U (1997) Semiquantitative analysis of
intrahepatic cytokine mRNAs in chronic hepatitis C. J Infect Dis
175: 681-685
[ 6] Eckels DD, Tabatabail N, Bian T-H, Wang H, Muheisen SS,
Rice CM, Yoshizawa K, Gill J (1999) In vitro human Th-cell
responses to a recombinant hepatitis C virus antigen: failure in IL-2
production despite proliferation. Hum Immunol 60: 187-199
[ 7] Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N,
Nogami C, Miyake T, Niigaki M, Tokuda A, Satoh S, Sakai S,
Akagi S, Watanabe M, Fukumoto S (1996) Intrahepatic express-
ion of pro-inflammatory cytokine mRNA and interferon effi-
cacy in chronic hepatitis C. Liver 16: 390-399.
[ 8] Gonzalez-Amaro R, Garcia-Monzon G, Garcia-Buey L, More-
no-Otero R, Alonso JL, Yague E, Pivel JP, Lopez-Cabrera M,
Fernandez-Ruiz E, Sanchez-Madrid F (1994) Induction of
tumor necrosis factor alpha production by human hepatocytes
in chronic viral hepatitis. J Exp Med 179: 841-848
[ 9] Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-perox-
idase complex (ABC) in immunoperoxidae techniques. J His-
tochem Cytochem 29: 577-580
[10] Kasprzak A, Biczysko W, Adamek A, Zabel M (2003) Morpho-
logical lesions detected by light and electron microscopies in
chronic type C hepatitis. Pol J Pathol 54: 129-142
[11] Kasprzak A, Seidel J, Spachacz R, Biczysko W, Małkowska A,
Kaczmarek E, Zabel M (2004) Intracellular expression of pro-
inflammatory cytokines (IL-1α, TNF-α, and IL-6) in chronic
hepatitis C. Ann Acad Med Bialost, Suppl 1: 207-209
[12] Kasprzak A, Zabel M (2001) Techniques of molecular biology
in morphological diagnosis of DNA and RNA viruses. Folia
Histochem Cytobiol 39: 97-98
[13] Kasprzak A, Zabel M, Biczysko W, Wysocki J, Adamek A,
Spachacz R, Surdyk-Zasada J (2004) Expression of cytokines
(TNF-α, IL-1α, and IL-2) in chronic hepatitis C: comparative
hybridocytochemical and immunocytochemical study in child-
ren and adult patients. J Histochem Cytochem 52: 29-38
[14] Kasprzak A, Seidel J, Biczysko W, Wysocki J, Spachacz R,
Zabel M (2005) Intracellular localization of hepatitis C virus
proteins (NS3 and C) in children with chronic hepatitis C. Liver
Int 25: 896-903
[15] Komminoth P, Werner M (1997) Target and signal amplifica-
tion: approaches to increase the sensivity of in situ hybridiza-
tion. Histochem Cell Biol 108: 325-333
[16] Koziel MJ (1999) Cytokines in viral hepatitis. Semin Liver Dis
19: 157-169
[17] Larrea E, Garcia N, Qian C, Civeira MP, Prieto J (1996) Tumor
necrosis factor alpha gene expression and the response to inter-
feron in chronic hepatitis C. Hepatology 23: 210-217
[18] Lenardo M (1991) Interleukin-2 programs mouse alpha beta
T lymphocytes for apoptosis. Nature 353: 858-861
[19] McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel
NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu
D, Slaitini L, Church WB, Napoli J (2000) Molecular pathogen-
esis of liver disease: an approach to hepatic inflammation,
cirrhosis and liver transplant tolerance. Immunol Rev 174:
172-191
[20] Morshed SA, Fukuma H, Kimura Y, Watanabe S, Nishioka M
(1993) Interferon-gamma, interleukin (IL)-2 and IL-2 receptor
expression in hepatitis C virus-infected liver. Gastroenterol Jpn,
Suppl 5: 59-66
[21] Napoli J, Bishop GA, McGuinness PH, Painter DM,
McCaughan GW (1996) Progressive liver injury in chronic
hepatitis C infection correlates with increased intrahepatic
expression of Th1-associated cytokines. Hepatology 24:
759-765
[22] Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon
SM, Weinman SA (2002) Mitochondrial injury, oxidative
stress, and antioxidant gene expression are induced by hepatitis
C virus core protein. Gastroenterology 122: 366-375
[23] Oyanagi Y, Takahashi T, Matsui S, Takahashi S, Boku S,
Takahashi K, Furukawa K, Arai F, Asakura H (1999) Enhanced
expression of interleukin-6 in chronic hepatitis C. Liver 19:
464-472
[24] Peters M (1996) Action of cytokines on the immune response
and viral interactions: an overview. Hepatology 23: 911-916
[25] Reichert TE, Watkins S, Stanson J, Johnson JT, Whiteside TL
(1998) Endogenous IL-2 in cancer cells: a marker of cellular
proliferation. J Histochem Cytochem 46: 603-611
[26] Scheuer PJ, Standish RA, Dhillon AP (2002) Scoring of chronic
hepatitis. Clin Liver Dis 6: 335-347
[27] Seidel J, Zabel M (2001) Application of colloidal gold to
ultrastructural studies. Folia Histochem Cytobiol 39: 107-108
[28] Shapiro S, Gerstein V, Elias N, Zuckerman E, Salman N, Lahat
N (1998) mRNA cytokine profile in peripheral blood cells from
chronic hepatitis C virus (HCV)-infected patients: effects of
interferon-alpha (IFN-alpha) treatment. Clin Exp Immunol 114:
55-60
[29] Smith KA. Interleukin 2 (1984) Annu Rev Immunol 2: 319-333
[30] Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier
G, Huber C (1992) Serum levels of cytokine in chronic liver
diseases. Gastroenterology 103: 264-274
[31] Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V,
Haouzi D, Berson A, Pessayre D (1999) Interleukin-2 overex-
presses c-myc and down-regulates cytochrome P-450 in rat
hepatocytes. J Pharmacol Exp Therap 289: 649-655
[32] Wang H, Eckels DD (1999) Mutations in immunodominant T
cell epitopes derived from the nonstructural 3 protein of he-
patitis C virus have the potential for generating escape variants
that may have important consequences for T cell recognition. J
Immunol 162: 4177-4183
Received: July 1, 2005
Accepted after revision: October 18, 2005
 110  A. Kasprzak  et al.
